Govt plans two new labs to test drug samples

NEW DELHI: In a move to ensure safer medicines, the Centre plans to designate two new laboratories — in Mumbai and Chennai — as ‘appellate testing laboratories’, to check drug samples collected by regulators as part of market surveillance and plant inspections.

While the labs in Chennai and Mumbai are fully equipped, they have so far been used by state regulators. The central regulator will upgrade them to ensure they are prepared to deal with demands.

The new laboratories will add to the government’s capacity to test samples as currently there is only one such central drug testing lab in Kolkata. The central facilities are expected to improve standards and also be less susceptible to manipulation as they will function under government supervision. The different laboratories will enable samples being randomly sent to any of the facilities for testing.

Apart from random sampling from the market and products that seek approvals from the regulator, the central drugs standard control organisation also undertakes a massive exercise annually, which involves collection of around 50,000 samples from across the country to check counterfeiting and ensure quality of medicines. All these samples were so far sent to the Kolkata laboratory.

Now, with government planning to increase frequency of inspections as well as fast track process to process approvals in time, capacity and fidelity of testing has emerged as a major concern.

“At present companies know where we are sending product samples and can sometimes manage the system. Designating multiple laboratories can check this,” an official said.

The proposal is part of the agenda to be taken up by the drug regulatory Drugs Technical Advisory Board for final approval in its upcoming meeting by end of this month.

In absence of authentic data, regulators struggle to keep a check on quality of products being sold to patients. Quality assumes significance as India is the largest supplier of low-priced generic medicines to the world and has faced strong criticism on standards.

  • Related Posts

    • Pharma
    • March 27, 2024
    • 105 views
    Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

    Haryana has blacklisted Maiden Pharmaceuticals Ltd, based at Sonepat, for three years, thereby debarring the firm from participating in state tenders. All rate contracts issued to the firm have also…

    • Pharma
    • March 27, 2024
    • 69 views
    DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

    New Delhi: The Drugs Consultative Committee (DCC), the advisory committee formed by the Central government to advise the Central and state governments on matters that require uniform implementation of drug laws…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

    Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

    DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

    DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

    Sanofi, Cipla Join Hands To Expand Reach Of CNS Portfolio In India

    Sanofi, Cipla Join Hands To Expand Reach Of CNS Portfolio In India

    Cyberabad Police Seize 1 Kg Alprazolam, Arrest Three

    Cyberabad Police Seize 1 Kg Alprazolam, Arrest Three

    Lee Health develops natural capsule for effective Heart care

    Lee Health develops natural capsule for effective Heart care

    Medical Shop Run By Twenty20 In Kizhakkambalam Asked To Shut Down

    Medical Shop Run By Twenty20 In Kizhakkambalam Asked To Shut Down